外泌体递送超阻遏物IκBα改善肾脏缺血再灌注损伤
本研究利用光遗传工程化外泌体技术EXPLOR,将NF-κB超阻遏物IκBα(Exo-srIκB)递送至B6野生型小鼠缺血再灌注肾损伤模型,与对照外泌体(Exo-Naïve)比较。结果显示Exo-srIκB降低血清尿素氮、肌酐和NGAL水平,减少肾脏NF-κB活性与凋亡,下调促炎细胞因子和黏附分子表达,并降低中性粒细胞、单核/巨噬细胞及T细胞频率。提示外泌体调控NF-κB信号可作为缺血再灌注急性肾损伤的新型治疗策略。
要点
- Exo-srIκB可降低缺血再灌注小鼠血清尿素氮、肌酐和NGAL水平。
- Exo-srIκB抑制缺血后肾脏NF-κB活性并减少细胞凋亡。
- 外泌体被中性粒细胞和巨噬细胞摄取,并改变肾脏免疫细胞群体。
核心结论
- 通过外泌体递送超阻遏物IκBα调控NF-κB信号,可改善缺血再灌注诱导的急性肾损伤。
研究设计与样本
- 在B6野生型小鼠肾脏缺血再灌注手术前/后,使用EXPLOR光遗传工程化外泌体技术递送Exo-srIκB,并与注射对照外泌体Exo-Naïve的组比较结局。
主要发现
- Exo-srIκB治疗组缺血后小鼠血清尿素氮、肌酐和中性粒细胞明胶酶相关脂质运载蛋白水平低于Exo-Naïve组。
- 全身递送Exo-srIκB降低缺血后肾脏NF-κB活性并减少凋亡。
- 与对照相比,Exo-srIκB治疗降低缺血后肾脏促炎细胞因子和黏附分子的基因表达。
- 活体成像 confirmed 外泌体被中性粒细胞和巨噬细胞摄取。
- Exo-srIκB治疗显著影响缺血后肾脏免疫细胞群体,降低中性粒细胞、单核/巨噬细胞和T细胞频率。
临床怎么用
- 外泌体介导的NF-κB信号调控可能成为缺血再灌注急性肾损伤的新型治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischemia-reperfusion injury is a major cause of acute kidney injury. Recent studies on the pathophysiology of ischemia-reperfusion-induced acute kidney injury showed that immunologic responses significantly affect kidney ischemia-reperfusion injury and repair. Nuclear factor (NF)-ĸB signaling, which controls cytokine production and cell survival, is significantly involved in ischemia-reperfusion-induced acute kidney injury, and its inhibition can ameliorate ischemic acute kidney injury. Using EXPLOR, a novel, optogenetically engineered exosome technology, we successfully delivered the exosomal super-repressor inhibitor of NF-ĸB (Exo-srIĸB) into B6 wild type mice before/after kidney ischemia-reperfusion surgery, and compared outcomes with those of a control exosome (Exo-Naïve)-injected group. Exo-srIĸB treatment resulted in lower levels of serum blood urea nitrogen, creatinine, and neutrophil gelatinase-associated lipocalin in post-ischemic mice than in the Exo-Naïve treatment group. Systemic delivery of Exo-srIĸB decreased NF-ĸB activity in post-ischemic kidneys and reduced apoptosis. Post-ischemic kidneys showed decreased gene expression of pro-inflammatory cytokines and adhesion molecules with Exo-srIĸB treatment as compared with the control. Intravital imaging confirmed the uptake of exosomes in neutrophils and macrophages. Exo-srIĸB treatment also significantly affected post-ischemic kidney immune cell populations, lowering neutrophil, monocyte/macrophage, and T cell frequencies than those in the control. Thus, modulation of NF-ĸB signaling through exosomal delivery can be used as a novel therapeutic method for ischemia-reperfusion-induced acute kidney injury.
引用
- Kim S, Lee SA, Yoon H, et al. Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury. Kidney Int. 2021. PMID: 34051264. doi:10.1016/j.kint.2021.04.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。